Clinical Research in Cardiology

, Volume 98, Issue 3, pp 141–158

Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare “disease of the desmosome” with multiple clinical presentations

REVIEW

Abstract

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a rare but increasingly recognized form of a cardiomyopathy, involving primarily the right ventricle. Mutations in seven candidate genes coding for five desmosomal proteins (plakoglobin, plakophilin-2, desmoplakin, desmoglein-2, desmocollin-2), for the cardiac ryanodine receptor-2, for the transforming growth factor beta-3, and for the transmembrane protein 43, respectively, are pathogenetically important. A typical feature of the disease is the replacement of the right ventricular myocardium by fibrofatty infiltrates, leading to electrical instability including ventricular arrhythmias in the early stages, and reduced contractility and heart failure later on. The left ventricle may also be involved. Unfortunately, the disease is often diagnosed post mortem only, especially in young adults dying suddenly during exercise. Since the disease is inherited in up to 50% of cases, the screening of relatives is important. The implantable cardioverter defibrillator is an important therapeutic tool. Nevertheless, the mortality of the disease remains to be 2%–4% per year. Several clinical, electrocardiographic, and imaging parameters were identified as risk predictors for an adverse outcome. In this paper, we describe distinct clinical presentations of ARVC/D, review the genetic background of the disease, and discuss its diagnosis and treatment.

Keywords

cardiomyopathy right ventricle sudden death heart failure exercise desmosome ICD 

References

  1. 1.
    (2005) 2005 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 112:IV1–203Google Scholar
  2. 2.
    Ahmad F, Li D, Karibe A, Gonzalez O, Tapscott T, Hill R, Weilbaecher D, Blackie P, Furey M, Gardner M, Bachinski LL, Roberts R (1998) Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23. Circulation 98:2791–2795PubMedGoogle Scholar
  3. 3.
    Ainsworth CD, Skanes AC, Klein GJ, Gula LJ, Yee R, Krahn AD (2006) Differentiating arrhythmogenic right ventricular cardiomyopathy from right ventricular outflow tract ventricular tachycardia using multilead QRS duration and axis. Heart Rhythm 3:416–423PubMedCrossRefGoogle Scholar
  4. 4.
    Ananthasubramaniam K, Khaja F (1998) Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Review for the clinician. Prog Cardiovasc Dis 41:237–246PubMedCrossRefGoogle Scholar
  5. 5.
    Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A (2005) Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 111:659–670PubMedCrossRefGoogle Scholar
  6. 6.
    Asimaki A, Syrris P, Wichter T, Matthias P, Saffitz JE, McKenna WJ (2007) A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 81:964–973PubMedCrossRefGoogle Scholar
  7. 7.
    Auffermann W, Wichter T, Breithardt G, Joachimsen K, Peters PE (1993) Arrhythmogenic right ventricular disease: MR imaging vs angiography. AJR Am J Roentgenol 161:549–555PubMedGoogle Scholar
  8. 8.
    Avella A, d’Amati G, Pappalardo A, Re F, Francesca Silenzi P, Laurenzi F, P DEG, Pelargonio G, Dello Russo A, Baratta P, Messina G, Zecchi P, Zachara E, Tondo C (2008) Diagnostic value of endomyocardial biopsy guided by electroanatomic voltage mapping in arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Cardiovasc Electrophysiol (in press)Google Scholar
  9. 9.
    Awad MM, Dalal D, Cho E, Amat-Alarcon N, James C, Tichnell C, Tucker A, Russell SD, Bluemke DA, Dietz HC, Calkins H, Judge DP (2006) DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Hum Genet 79:136–142PubMedCrossRefGoogle Scholar
  10. 10.
    Bakir I, Brugada P, Sarkozy A, Vandepitte C, Wellens F (2007) A novel treatment strategy for therapy refractory ventricular arrhythmias in the setting of arrhythmogenic right ventricular dysplasia. Europace 9:267–269PubMedCrossRefGoogle Scholar
  11. 11.
    Basso C, Czarnowska E, Barbera MD, Bauce B, Beffagna G, Wlodarska EK, Pilichou K, Ramondo A, Lorenzon A, Wozniek O, Corrado D, Daliento L, Danieli GA, Valente M, Nava A, Thiene G, Rampazzo A (2006) Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. Eur Heart J 27:1847–1854PubMedCrossRefGoogle Scholar
  12. 12.
    Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M (1996) Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation 94:983–991PubMedGoogle Scholar
  13. 13.
    Basso C, Wichter T, Danieli GA, Corrado D, Czarnowska E, Fontaine G, McKenna WJ, Nava A, Protonotarios N, Antoniades L, Wlodarska K, D’Alessi F, Thiene G (2004) Arrhythmogenic right ventricular cardiomyopathy: clinical registry and database, evaluation of therapies, pathology registry, DNA banking. Eur Heart J 25:531–534PubMedCrossRefGoogle Scholar
  14. 14.
    Bauce B, Basso C, Rampazzo A, Beffagna G, Daliento L, Frigo G, Malacrida S, Settimo L, Danieli G, Thiene G, Nava A (2005) Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J 26:1666–1675PubMedCrossRefGoogle Scholar
  15. 15.
    Bauce B, Nava A, Rampazzo A, Daliento L, Muriago M, Basso C, Thiene G, Danieli GA (2000) Familial effort polymorphic ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy map to chromosome 1q42–43. Am J Cardiol 85:573–579PubMedCrossRefGoogle Scholar
  16. 16.
    Beffagna G, Occhi G, Nava A, Vitiello L, Ditadi A, Basso C, Bauce B, Carraro G, Thiene G, Towbin JA, Danieli GA, Rampazzo A (2005) Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res 65:366–373PubMedCrossRefGoogle Scholar
  17. 17.
    Blomstrom-Lundqvist C, Sabel KG, Olsson SB (1987) A long-term follow-up of 15 patients with arrhythmogenic right ventricular dysplasia. Br Heart J 57:477–488CrossRefGoogle Scholar
  18. 18.
    Bluemke DA, Krupinski EA, Ovitt T, Gear K, Unger E, Axel L, Boxt LM, Casolo G, Ferrari VA, Funaki B, Globits S, Higgins CB, Julsrud P, Lipton M, Mawson J, Nygren A, Pennell DJ, Stillman A, White RD, Wichter T, Marcus F (2003) MR Imaging of arrhythmogenic right ventricular cardiomyopathy: morphologic findings and interobserver reliability. Cardiology 99:153–162PubMedCrossRefGoogle Scholar
  19. 19.
    Bomma C, Dalal D, Tandri H, Prakasa K, Nasir K, Roguin A, Piccini J, Dong J, Mahadevappa M, Tichnell C, James C, Lima JA, Fishman E, Calkins H, Bluemke DA (2007) Evolving role of multidetector computed tomography in evaluation of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Cardiol 100:99–105PubMedCrossRefGoogle Scholar
  20. 20.
    Bomma C, Rutberg J, Tandri H, Nasir K, Roguin A, Tichnell C, Rodriguez R, James C, Kasper E, Spevak P, Bluemke DA, Calkins H (2004) Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol 15:300–306PubMedGoogle Scholar
  21. 21.
    Boriani G, Artale P, Biffi M, Martignani C, Frabetti L, Valzania C, Diemberger I, Ziacchi M, Bertini M, Rapezzi C, Parlapiano M, Branzi A (2007) Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Vessels 22:184–192PubMedCrossRefGoogle Scholar
  22. 22.
    Bowles NE, Ni J, Marcus F, Towbin JA (2002) The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 39:892–895PubMedCrossRefGoogle Scholar
  23. 23.
    Breithardt G, Wichter T, Haverkamp W, Borggrefe M, Block M, Hammel D, Scheld HH (1994) Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. Am Heart J 127:1151–1158PubMedCrossRefGoogle Scholar
  24. 24.
    Burke AP, Farb A, Tashko G, Virmani R (1998) Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? Circulation 97:1571–1580PubMedGoogle Scholar
  25. 25.
    Candinas R, Duru F (2001) Unusual clinical presentation of a patient with an extreme form of right ventricular dysplasia. Circulation 104:848–849PubMedCrossRefGoogle Scholar
  26. 26.
    Chachques JC, Argyriadis PG, Fontaine G, Hebert JL, Frank RA, D’Attellis N, Fabiani JN, Carpentier AF (2003) Right ventricular cardiomyoplasty: 10-year follow-up. Ann Thorac Surg 75:1464–1468PubMedCrossRefGoogle Scholar
  27. 27.
    Chaitman BR (2007) An electrocardiogram should not be included in routine preparticipation screening of young athletes. Circulation 116:2610–2614 (discussion 2615)PubMedCrossRefGoogle Scholar
  28. 28.
    Coonar AS, Protonotarios N, Tsatsopoulou A, Needham EW, Houlston RS, Cliff S, Otter MI, Murday VA, Mattu RK, McKenna WJ (1998) Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation 97:2049–2058PubMedGoogle Scholar
  29. 29.
    Corrado D, Basso C, Leoni L, Tokajuk B, Bauce B, Frigo G, Tarantini G, Napodano M, Turrini P, Ramondo A, Daliento L, Nava A, Buja G, Iliceto S, Thiene G (2005) Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 111:3042–3050PubMedCrossRefGoogle Scholar
  30. 30.
    Corrado D, Basso C, Nava A, Thiene G (2001) Arrhythmogenic right ventricular cardiomyopathy: current diagnostic and management strategies. Cardiol Rev 9:259–265PubMedCrossRefGoogle Scholar
  31. 31.
    Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G (2006) Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 296:1593–1601PubMedCrossRefGoogle Scholar
  32. 32.
    Corrado D, Basso C, Schiavon M, Thiene G (1998) Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 339:364–369PubMedCrossRefGoogle Scholar
  33. 33.
    Corrado D, Basso C, Thiene G, McKenna WJ, Davies MJ, Fontaliran F, Nava A, Silvestri F, Blomstrom-Lundqvist C, Wlodarska EK, Fontaine G, Camerini F (1997) Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 30:1512–1520PubMedCrossRefGoogle Scholar
  34. 34.
    Corrado D, Fontaine G, Marcus FI, McKenna WJ, Nava A, Thiene G, Wichter T (2000) Arrhythmogenic right ventricular dysplasia/cardiomyopathy. Need for an international registry. Circulation 101:e101–e106PubMedGoogle Scholar
  35. 35.
    Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, Curnis A, Salerno JU, Igidbashian D, Raviele A, Disertori M, Zanotto G, Verlato R, Vergara G, Delise P, Turrini P, Basso C, Naccarella F, Maddalena F, Estes NA, 3rd, Buja G, Thiene G (2003) Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 108:3084–3091PubMedCrossRefGoogle Scholar
  36. 36.
    d’Amati G, di Gioia CR, Giordano C, Gallo P (2000) Myocyte transdifferentiation: a possible pathogenetic mechanism for arrhythmogenic right ventricular cardiomyopathy. Arch Pathol Lab Med 124:287–290PubMedGoogle Scholar
  37. 37.
    Dalal D, Jain R, Tandri H, Dong J, Eid SM, Prakasa K, Tichnell C, James C, Abraham T, Russell SD, Sinha S, Judge DP, Bluemke DA, Marine JE, Calkins H (2007) Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 50:432–440PubMedCrossRefGoogle Scholar
  38. 38.
    Dalal D, Molin LH, Piccini J, Tichnell C, James C, Bomma C, Prakasa K, Towbin JA, Marcus FI, Spevak PJ, Bluemke DA, Abraham T, Russell SD, Calkins H, Judge DP (2006) Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation 113:1641–1649PubMedCrossRefGoogle Scholar
  39. 39.
    Fischer AH, Van der Loo B, Schär GM, Zbinden R, Duru F, Brunckhorst C, Rousson V, Delacrétaz E, Stuber T, Oechslin EN, Follath F, Jenni R (2008) Serological evidence fo the association of Bartonella henselae infection with arrhythmogenic right ventricular cardiomyopathy. Clin Cardiol (in press)Google Scholar
  40. 40.
    Fontaine G, Fontaliran F, Frank R (1998) Arrhythmogenic right ventricular cardiomyopathies. Clinical forms and main differential diagnoses (editorial). Circulation 97:1532–1535PubMedGoogle Scholar
  41. 41.
    Fontaine G, Fontaliran F, Hébert JL, Chemla D, Zenati O, Lecarpentier Y, Frank R (1999) Arrhythmogenic right ventricular dysplasia. Annu Rev Med 50:17–35PubMedCrossRefGoogle Scholar
  42. 42.
    Fontaine G, Tonet J, Gallais Y, Lascault G, Hidden-Lucet F, Aouate P, Halimi F, Poulain F, Johnson N, Charfeddine H, Frank R (2000) Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia: a 16-year experience. Curr Cardiol Rep 2:498–506PubMedCrossRefGoogle Scholar
  43. 43.
    Frank R, Fontaine G, Vedel J, Mialet G, Sol C, Guiraudon G, Grosgogeat Y (1978) [Electrocardiology of 4 cases of right ventricular dysplasia inducing arrhythmia]. Arch Mal Coeur Vaiss 71:963–972PubMedGoogle Scholar
  44. 44.
    Franke WW, Borrmann CM, Grund C, Pieperhoff S (2006) The area composita of adhering junctions connecting heart muscle cells of vertebrates. I. Molecular definition in intercalated disks of cardiomyocytes by immunoelectron microscopy of desmosomal proteins. Eur J Cell Biol 85:69–82PubMedCrossRefGoogle Scholar
  45. 45.
    Garcia-Gras E, Lombardi R, Giocondo MJ, Willerson JT, Schneider MD, Khoury DS, Marian AJ (2006) Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest 116:2012–2021PubMedCrossRefGoogle Scholar
  46. 46.
    Gerull B, Heuser A, Wichter T, Paul M, Basson CT, McDermott DA, Lerman BB, Markowitz SM, Ellinor PT, MacRae CA, Peters S, Grossmann KS, Drenckhahn J, Michely B, Sasse-Klaassen S, Birchmeier W, Dietz R, Breithardt G, Schulze-Bahr E, Thierfelder L (2004) Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 36:1162–1164PubMedCrossRefGoogle Scholar
  47. 47.
    Girard F, Fontaine G, Fontaliran F, Zenati O, Gajdos P (1997) Catastrophic global heart failure in a patient with non-arrhythmogenic right ventricular dysplasia. Heart Vessels 12:152–154PubMedCrossRefGoogle Scholar
  48. 48.
    Green KJ, Gaudry CA (2000) Are desmosomes more than tethers for intermediate filaments? Nat Rev Mol Cell Biol 1:208–216PubMedCrossRefGoogle Scholar
  49. 49.
    Hamid MS, Norman M, Quraishi A, Firoozi S, Thaman R, Gimeno JR, Sachdev B, Rowland E, Elliott PM, McKenna WJ (2002) Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 40:1445–1450PubMedCrossRefGoogle Scholar
  50. 50.
    Hebert JL, Chemla D, Gerard O, Zamani K, Quillard J, Azarine A, Frank R, Lecarpentier Y, Fontaine G (2004) Angiographic right and left ventricular function in arrhythmogenic right ventricular dysplasia. Am J Cardiol 93:728–733PubMedCrossRefGoogle Scholar
  51. 51.
    Heidbuchel H, Corrado D, Biffi A, Hoffmann E, Panhuyzen-Goedkoop N, Hoogsteen J, Delise P, Hoff PI, Pelliccia A (2006) Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions Part II: Ventricular arrhythmias, channelopathies and implantable defibrillators. Eur J Cardiovasc Prev Rehabil 13:676–686PubMedCrossRefGoogle Scholar
  52. 52.
    Heidbuchel H, Hoogsteen J, Fagard R, Vanhees L, Ector H, Willems R, Van Lierde J (2003) High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. Eur Heart J 24:1473–1480PubMedCrossRefGoogle Scholar
  53. 53.
    Heuser A, Plovie ER, Ellinor PT, Grossmann KS, Shin JT, Wichter T, Basson CR, Lerman BB, Sasse-Klaassen S, Thierfelder L, MacRae CA, Gerull B (2006) Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy Am J Hum Genet 79:1081–1088PubMedCrossRefGoogle Scholar
  54. 54.
    Ho SY, Nihoyannopoulos P (2006) Anatomy, echocardiography, and normal right ventricular dimensions. Heart 92(Suppl 1):i2–13PubMedCrossRefGoogle Scholar
  55. 55.
    Hodgkinson KA, Parfrey PS, Bassett AS, Kupprion C, Drenckhahn J, Norman MW, Thierfelder L, Stuckless SN, Dicks EL, McKenna WJ, Connors SP (2005) The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J Am Coll Cardiol 45:400–408PubMedCrossRefGoogle Scholar
  56. 56.
    Holzmann M, Nicko A, Kuhl U, Noutsias M, Poller W, Hoffmann W, Morguet A, Witzenbichler B, Tschope C, Schultheiss HP, Pauschinger M (2008) Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 118:1722–1728PubMedCrossRefGoogle Scholar
  57. 57.
    Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G (2004) Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 110:1879–1884PubMedCrossRefGoogle Scholar
  58. 58.
    Indik JH, Wichter T, Gear K, Dallas WJ, Marcus FI (2008) Quantitative assessment of angiographic right ventricular wall motion in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). J Cardiovasc Electrophysiol 19:39–45PubMedCrossRefGoogle Scholar
  59. 59.
    Jain A, Tandri H, Calkins H, Bluemke DA (2008) Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia. J Cardiovasc Magn Reson 10:32PubMedCrossRefGoogle Scholar
  60. 60.
    Kaplan SR, Gard JJ, Protonotarios N, Tsatsopoulou A, Spiliopoulou C, Anastasakis A, Squarcioni CP, McKenna WJ, Thiene G, Basso C, Brousse N, Fontaine G, Saffitz JE (2004) Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm 1:3–11PubMedCrossRefGoogle Scholar
  61. 61.
    Keller DI, Osswald S, Bremerich J, Bongartz G, Cron TA, Hilti P, Pfisterer ME, Buser PT (2003) Arrhythmogenic right ventricular cardiomyopathy: diagnostic and prognostic value of the cardiac MRI in relation to arrhythmia-free survival. Int J Cardiovasc Imaging 19:537–543 (discussion 545–537)PubMedCrossRefGoogle Scholar
  62. 62.
    Kies P, Bootsma M, Bax JJ, Zeppenfeld K, van Erven L, Wijffels MC, van der Wall EE, Schalij MJ (2006) Serial reevaluation for ARVD/C is indicated in patients presenting with left bundle branch block ventricular tachycardia and minor ECG abnormalities. J Cardiovasc Electrophysiol 17:586–593PubMedCrossRefGoogle Scholar
  63. 63.
    Kinoshita O, Fontaine G, Rosas F, Elias J, Iwa T, Tonet J, Lascault G, Frank R (1995) Time- and frequency-domain analyses of the signal-averaged ECG in patients with arrhythmogenic right ventricular dysplasia. Circulation 91:715–721PubMedGoogle Scholar
  64. 64.
    Kirchhof P, Fabritz L, Zwiener M, Witt H, Schafers M, Zellerhoff S, Paul M, Athai T, Hiller KH, Baba HA, Breithardt G, Ruiz P, Wichter T, Levkau B (2006) Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 114:1799–1806PubMedCrossRefGoogle Scholar
  65. 65.
    Kjaergaard J, Hastrup Svendsen J, Sogaard P, Chen X, Bay Nielsen H, Kober L, Kjaer A, Hassager C (2007) Advanced quantitative echocardiography in arrhythmogenic right ventricular cardiomyopathy. J Am Soc Echocardiogr 20:27–35PubMedCrossRefGoogle Scholar
  66. 66.
    Kuck KH, Ernst S, Dorwarth U, Hoffmann E, Pitschner H, Tebbenjohanns J, Kottkamp H (2007) Guidelines for catheter ablation. Clin Res Cardiol 96:833–849PubMedCrossRefGoogle Scholar
  67. 67.
    Lahtinen AM, Lehtonen A, Kaartinen M, Toivonen L, Swan H, Widen E, Lehtonen E, Lehto VP, Kontula K (2008) Plakophilin-2 missense mutations in arrhythmogenic right ventricular cardiomyopathy. Int J Cardiol 126:92–100PubMedCrossRefGoogle Scholar
  68. 68.
    Lemola K, Brunckhorst C, Helfenstein U, Oechslin E, Jenni R, Duru F (2005) Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long-term experience of a tertiary care centre. Heart 91:1167–1172PubMedCrossRefGoogle Scholar
  69. 69.
    Li D, Ahmad F, Gardner M, Weilbaecher D, Hill R, Karibe A (2000) The locus of a novel gene responsible for arrhythmogenic right ventricular dyplasia characterized by early onset and high penetrance maps to chromosome 10p12–p14. Am J Hum Genet 66:148–156PubMedCrossRefGoogle Scholar
  70. 70.
    Li D, Bachinski LL, Roberts R (2001) Genomic organization and isoform-specific tissue expression of human NAPOR (CUGBP2) as a candidate gene for familial arrhythmogenic right ventricular dysplasia. Genomics 74:396–401PubMedCrossRefGoogle Scholar
  71. 71.
    Lindstrom L, Wilkenshoff UM, Larsson H, Wranne B (2001) Echocardiographic assessment of arrhythmogenic right ventricular cardiomyopathy. Heart 86:31–38PubMedCrossRefGoogle Scholar
  72. 72.
    Link MS, Wang PJ, Haugh CJ, Homoud MK, Foote CB, Costeas XB, Estes NA, 3rd (1997) Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators. J Interv Card Electrophysiol 1:41–48PubMedCrossRefGoogle Scholar
  73. 73.
    Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G (1996) Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 335:1190–1196PubMedCrossRefGoogle Scholar
  74. 74.
    Marchlinski FE, Zado E, Dixit S, Gerstenfeld E, Callans DJ, Hsia H, Lin D, Nayak H, Russo A, Pulliam W (2004) Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation 110:2293–2298PubMedCrossRefGoogle Scholar
  75. 75.
    Marcus F, Towbin JA, Zareba W, Moss A, Calkins H, Brown M, Gear K (2003) Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a multidisciplinary study: design and protocol. Circulation 107:2975–2978PubMedCrossRefGoogle Scholar
  76. 76.
    Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, Grosgogeat Y (1982) Right ventricular dysplasia: a report of 24 adult cases. Circulation 65:384–398PubMedGoogle Scholar
  77. 77.
    Maron BJ, Ackerman MJ, Nishimura RA, Pyeritz RE, Towbin JA, Udelson JE (2005) 36th Bethesda Conference. Eligibility recommendations for competitive athletes with cardiovascular abnormalities. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol 45:1340–1345PubMedCrossRefGoogle Scholar
  78. 78.
    Maron BJ, Chaitman BR, Ackerman MJ, Bayes de Luna A, Corrado D, Crosson JE, Deal BJ, Driscoll DJ, Estes NA, 3rd, Araujo CG, Liang DH, Mitten MJ, Myerburg RJ, Pelliccia A, Thompson PD, Towbin JA, Van Camp SP (2004) Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 109:2807–2816PubMedCrossRefGoogle Scholar
  79. 79.
    Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, Dimeff R, Douglas PS, Glover DW, Hutter AM, Jr., Krauss MD, Maron MS, Mitten MJ, Roberts WO, Puffer JC (2007) Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 115:1643–1455CrossRefGoogle Scholar
  80. 80.
    Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807–1816PubMedCrossRefGoogle Scholar
  81. 81.
    McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F (1994) Diagnosis of arrhythmogenic rigth ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 71:215–218PubMedCrossRefGoogle Scholar
  82. 82.
    McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, Norman M, Baboonian C, Jeffery S, McKenna WJ (2000) Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355:2119–2124PubMedCrossRefGoogle Scholar
  83. 83.
    Melberg A, Oldfors A, Blomstrom-Lundqvist C, Stalberg E, Carlsson B, Larrson E, Lidell C, Eeg-Olofsson KE, Wikstrom G, Henriksson G, Dahl N (1999) Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy linked to chromosome 10q. Ann Neurol 46:684–692CrossRefGoogle Scholar
  84. 84.
    Merner ND, Hodgkinson KA, Haywood AF, Connors S, French VM, Drenckhahn JD, Kupprion C, Ramadanova K, Thierfelder L, McKenna W, Gallagher B, Morris-Larkin L, Bassett AS, Parfrey PS, Young TL (2008) Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet 82:809–821PubMedCrossRefGoogle Scholar
  85. 85.
    Muthappan P, Calkins H (2008) Arrhythmogenic right ventricular dysplasia. Prog Cardiovasc Dis 51:31–43PubMedCrossRefGoogle Scholar
  86. 86.
    Myerburg RJ, Vetter VL (2007) Electrocardiograms should be included in preparticipation screening of athletes. Circulation 116:2616–2626; discussion 2626PubMedCrossRefGoogle Scholar
  87. 87.
    Nasir K, Bomma C, Tandri H, Roguin A, Dalal D, Prakasa K, Tichnell C, James C, Jspevak P, Marcus F, Calkins H (2004) Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Circulation 110:1527–1534PubMedCrossRefGoogle Scholar
  88. 88.
    Nasir K, Rutberg J, Tandri H, Berger R, Tomaselli G, Calkins H (2003) Utility of SAECG in arrhythmogenic right ventricle dysplasia. Ann Noninvasive Electrocardiol 8:112–120PubMedCrossRefGoogle Scholar
  89. 89.
    Nava A, Folino AF, Bauce B, Turrini P, Buja GF, Daliento L, Thiene G (2000) Signal-averaged electrocardiogram in patients with arrhythmogenic right ventricular cardiomyopathy and ventricular arrhythmias. Eur Heart J 21:58–65PubMedCrossRefGoogle Scholar
  90. 90.
    Nemec J, Edwards BS, Osborn MJ, Edwards WD (1999) Arrhythmogenic right ventricular dysplasia masquerading as dilated cardiomyopathy. Am J Cardiol 84:237–239PubMedCrossRefGoogle Scholar
  91. 91.
    Niroomand F, Carbucicchio C, Tondo C, Riva S, Fassini G, Apostolo A, Trevisi N, Bella PD (2002) Electrophysiological characteristics and outcome in patients with idiopathic right ventricular arrhythmia compared with arrhythmogenic right ventricular dysplasia. Heart 87:41–47PubMedCrossRefGoogle Scholar
  92. 92.
    Ott P, Marcus FI, Sobonya RE, Morady F, Knight BP, Fuenzalida CE (2003) Cardiac sarcoidosis masquerading as right ventricular dysplasia. Pacing Clin Electrophysiol 26:1498–1503PubMedCrossRefGoogle Scholar
  93. 93.
    Pelliccia A, Di Paolo FM, Quattrini FM, Basso C, Culasso F, Popoli G, De Luca R, Spataro A, Biffi A, Thiene G, Maron BJ (2008) Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med 358:152–161PubMedCrossRefGoogle Scholar
  94. 94.
    Peters S, Trummel M (2003) Diagnosis of arrhythmogenic right ventricular dysplasia-cardiomyopathy: value of standard ECG revisited. Ann Noninvasive Electrocardiol 8:238–245PubMedCrossRefGoogle Scholar
  95. 95.
    Peters S, Trummel M, Meyners W (2004) Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital. Int J Cardiol 97:499–501PubMedCrossRefGoogle Scholar
  96. 96.
    Piccini JP, Dalal D, Roguin A, Bomma C, Cheng A, Prakasa K, Dong J, Tichnell C, James C, Russell S, Crosson J, Berger RD, Marine JE, Tomaselli G, Calkins H (2005) Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm 2:1188–1194PubMedCrossRefGoogle Scholar
  97. 97.
    Pilichou K, Nava A, Basso C, Beffagna G, Bauce B, Lorenzon A, Frigo G, Vettori A, Valente M, Towbin J, Thiene G, Danieli GA, Rampazzo A (2006) Mutations in desmoglein–2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation 113:1171–1179PubMedCrossRefGoogle Scholar
  98. 98.
    Pinamonti B, Sinagra G, Salvi A, Di Lenarda A, Morgera T, Silvestri F, Bussani R, Camerini F (1992) Left ventricular involvement in right ventricular dysplasia. Am Heart J 123:711–724PubMedCrossRefGoogle Scholar
  99. 99.
    Prakasa KR, Wang J, Tandri H, Dalal D, Bomma C, Chojnowski R, James C, Tichnell C, Russell S, Judge D, Corretti M, Bluemke D, Calkins H, Abraham TP (2007) Utility of tissue Doppler and strain echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Cardiol 100:507–512PubMedCrossRefGoogle Scholar
  100. 100.
    Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm AJ, Cappato R, Cobbe SM, Di Mario C, Maron BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJ, Zipes DP (2001) Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 22:1374–1450PubMedCrossRefGoogle Scholar
  101. 101.
    Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA (2001) Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103:196–200PubMedGoogle Scholar
  102. 102.
    Rampazzo A, Beffagna G, Nava A, Occhi G, Bauce B, Noiato M, Basso C, Frigo G, Thiene G, Towbin J, Danieli GA (2003) Arrhythmogenic right ventricular cardiomyopathy type 1 (ARVD1): confirmation of locus assignment and mutation screening of four candidate genes. Eur J Hum Genet 11:69–76PubMedCrossRefGoogle Scholar
  103. 103.
    Rampazzo A, Nava A, Danieli GA, Buja G, Daliento L, Fasoli G, Scognamiglio R, Corrado D, Thiene G (1994) The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet 3:959–962PubMedCrossRefGoogle Scholar
  104. 104.
    Rampazzo A, Nava A, Erne P, Eberhard M, Vian E, Slomp P, Tiso N, Thiene G, Danieli GA (1995) A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Hum Mol Genet 4:2151–2154PubMedCrossRefGoogle Scholar
  105. 105.
    Rampazzo A, Nava A, Malacrida S, Beffagna G, Bauce B, Rossi V, Zimbello R, Simionati B, Basso C, Thiene G, Towbin JA, Danieli GA (2002) Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 71:1200–1206PubMedCrossRefGoogle Scholar
  106. 106.
    Rampazzo A, Nava A, Miorin M, Fonderico P, Pope B, Tiso N, Livolsi B, Zimbello R, Thiene G, Danieli GA (1997) ARVD4, a new locus for arrhythmogenic right ventricular cardiomyopathy, maps to chromosome 2 long arm. Genomics 45:259–263PubMedCrossRefGoogle Scholar
  107. 107.
    Roguin A, Bomma CS, Nasir K, Tandri H, Tichnell C, James C, Rutberg J, Crosson J, Spevak PJ, Berger RD, Halperin HR, Calkins H (2004) Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 43:1843–1852PubMedCrossRefGoogle Scholar
  108. 108.
    Satomi K, Kurita T, Suyama K, Noda T, Okamura H, Otomo K, Shimizu W, Aihara N, Kamakura S (2006) Catheter ablation of stable and unstable ventricular tachycardias in patients with arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 17:469–476PubMedCrossRefGoogle Scholar
  109. 109.
    Sen-Chowdhry S, Lowe MD, Sporton SC, McKenna WJ (2004) Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management. Am J Med 117:685–695PubMedCrossRefGoogle Scholar
  110. 110.
    Sen-Chowdhry S, Prasad SK, Syrris P, Wage R, Ward D, Merrifield R, Smith GC, Firmin DN, Pennell DJ, McKenna WJ (2006) Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol 48:2132–2140PubMedCrossRefGoogle Scholar
  111. 111.
    Sen-Chowdhry S, Syrris P, McKenna WJ (2005) Genetics of right ventricular cardiomyopathy. J Cardiovasc Electrophysiol 16:927–935PubMedCrossRefGoogle Scholar
  112. 112.
    Sen-Chowdhry S, Syrris P, McKenna WJ (2007) Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 50:1813–1821PubMedCrossRefGoogle Scholar
  113. 113.
    Severini GM, Krajinovic M, Pinamonti BSG, Fioretti P, Brunazzi MC, Falaschi A, Camerini F, Giacca M, Mestroni L (1996) A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. Genomics 31:193–200PubMedCrossRefGoogle Scholar
  114. 114.
    Shen WK, Edwards WD, Hammill SC, Bailey KR, Ballard DJ, Gersh BJ (1995) Sudden unexpected nontraumatic death in 54 young adults: a 30-year population-based study. Am J Cardiol 76:148–152PubMedCrossRefGoogle Scholar
  115. 115.
    Syrris P, Ward D, Evans A, Asimaki A, Gandjbakhch E, Sen-Chowdhry S, McKenna WJ (2006) Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am J Hum Genet 79:978–984PubMedCrossRefGoogle Scholar
  116. 116.
    Tabib A, Loire R, Chalabreysse L, Meyronnet D, Miras A, Malicier D, Thivolet F, Chevalier P, Bouvagnet P (2003) Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation 108:3000–3005PubMedCrossRefGoogle Scholar
  117. 117.
    Tabib A, Loire R, Miras A, Thivolet-Bejui F, Timour Q, Bui-Xuan B, Malicier D (2000) Unsuspected cardiac lesions associated with sudden unexpected perioperative death. Eur J Anaesthesiol 17:230–235PubMedGoogle Scholar
  118. 118.
    Tandri H, Bomma C, Calkins H, Bluemke DA (2004) Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia. J Magn Reson Imaging 19:848–858PubMedCrossRefGoogle Scholar
  119. 119.
    Tandri H, Calkins H, Nasir K, Bomma C, Castillo E, Rutberg J, Tichnell C, Lima JA, Bluemke DA (2003) Magnetic resonance imaging findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 14:476–482PubMedCrossRefGoogle Scholar
  120. 120.
    Tandri H, Castillo E, Ferrari VA, Nasir K, Dalal D, Bomma C, Calkins H, Bluemke DA (2006) Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 48:2277–2284PubMedCrossRefGoogle Scholar
  121. 121.
    Tandri H, Saranathan M, Rodriguez ER, Martinez C, Bomma C, Nasir K, Rosen B, Lima JA, Calkins H, Bluemke DA (2005) Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 45:98–103PubMedCrossRefGoogle Scholar
  122. 122.
    Tavernier R, Gevaert S, De Sutter J, De Clercq A, Rottiers H, Jordaens L, Fonteyne W (2001) Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias. Heart 85:53–56PubMedCrossRefGoogle Scholar
  123. 123.
    Thiene G, Corrado D, Basso C (2007) Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Orphanet J Rare Dis 2:45PubMedCrossRefGoogle Scholar
  124. 124.
    Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, Larderet G, Brahmbhatt B, Brown K, Bauce B, Muriago M, Basso C, Thiene G, Danieli GA, Rampazzo A (2001) Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10:189–194PubMedCrossRefGoogle Scholar
  125. 125.
    Toh KW, Nadesan K, Sie MY, Vijeyasingam R, Tan PS (2004) Postoperative death in a patient with unrecognized arrhythmogenic right ventricular dysplasia syndrome. Anesth Analg 99:350–352 (table of contents)PubMedCrossRefGoogle Scholar
  126. 126.
    Tonet JL, Castro-Miranda R, Iwa T, Poulain F, Frank R, Fontaine GH (1991) Frequency of supraventricular tachyarrhythmias in arrhythmogenic right ventricular dysplasia. Am J Cardiol 67:1153PubMedCrossRefGoogle Scholar
  127. 127.
    Tsatsopoulou AA, Protonotarios NI, McKenna WJ (2006) Arrhythmogenic right ventricular dysplasia, a cell-adhesion cardiomyopathy: insights into disease pathogenesis from preliminary genotype-phenotype assessment. Heart 92:1720–1723PubMedCrossRefGoogle Scholar
  128. 128.
    Tuller D, Steiner M, Wahl A, Kabok M, Seiler C (2005) Systolic right ventricular function assessment by pulsed wave tissue Doppler imaging of the tricuspid annulus. Prospective analysis in 258 individuals. Swiss Med Wkly 135:461–468PubMedGoogle Scholar
  129. 129.
    Turrini P, Angelini A, Thiene G, Buja G, Daliento L, Rizzoli G, Nava A (1999) Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 83:1214–1219PubMedCrossRefGoogle Scholar
  130. 130.
    Turrini P, Corrado D, Basso C, Nava A, Bauce B, Thiene G (2001) Dispersion of ventricular depolarization-repolarization: a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation 103:3075–3080PubMedGoogle Scholar
  131. 131.
    van Tintelen JP, Entius MM, Bhuiyan ZA, Jongbloed R, Wiesfeld AC, Wilde AA, van der Smagt J, Boven LG, Mannens MM, van Langen IM, Hofstra RM, Otterspoor LC, Doevendans PA, Rodriguez LM, van Gelder IC, Hauer RN (2006) Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 113:1650–1658PubMedCrossRefGoogle Scholar
  132. 132.
    Verma A, Kilicaslan F, Schweikert RA, Tomassoni G, Rossillo A, Marrouche NF, Ozduran V, Wazni OM, Elayi SC, Saenz LC, Minor S, Cummings JE, Burkhardt JD, Hao S, Beheiry S, Tchou PJ, Natale A (2005) Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation 111:3209–3216PubMedCrossRefGoogle Scholar
  133. 133.
    Wichter T, Borggrefe M, Hoverkamp W, Chen X, Breithardt G (1992) Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease: results in patients with inducible and noninducible ventricular tachycardia. Circulation 86:29–37PubMedGoogle Scholar
  134. 134.
    Wichter T, Paul M, Wollmann C, Acil T, Gerdes P, Ashraf O, Tjan TD, Soeparwata R, Block M, Borggrefe M, Scheld HH, Breithardt G, Bocker D (2004) Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation 109:1503–1508PubMedCrossRefGoogle Scholar
  135. 135.
    Wichter T, Paul TM, Eckardt L, Gerdes P, Kirchhof P, Bocker D, Breithardt G (2005) Arrhythmogenic Right Ventricular Cardiomyopathy Antiarrhythmic Drugs, Catheter Ablation, or ICD? Herz 30:91–101PubMedCrossRefGoogle Scholar
  136. 136.
    Willems S, Eckardt L, Hoffmann E, Klemm H, Pitschner HF, Reithmann C, Tebbenjohanns J, Zrenner B (2007) [Guideline invasive electrophysiological diagnostics]. Clin Res Cardiol 96:634–651PubMedCrossRefGoogle Scholar
  137. 137.
    Wlodarska EK, Wozniak O, Konka M, Rydlewska-Sadowska W, Biederman A, Hoffman P (2006) Thromboembolic complications in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Europace 8:596–600PubMedCrossRefGoogle Scholar
  138. 138.
    Yoda M, Minami K, Fritzsche D, Tendrich G, Schulte-Eistrup S, Koerfer R (2005) Three cases of orthotopic heart transplantation for arrhythmogenic right ventricular cardiomyopathy. Ann Thorac Surg 80:2358–2360PubMedCrossRefGoogle Scholar
  139. 139.
    Yoerger DM, Marcus F, Sherrill D, Calkins H, Towbin JA, Zareba W, Picard MH (2005) Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia. J Am Coll Cardiol 45:860–865PubMedCrossRefGoogle Scholar
  140. 140.
    Zacharias J, Forty J, Colin Doig J, Bourke JP, Hilton CJ (2005) Right ventricular disarticulation. An 18-year single centre experience. Eur J Cardiothorac Surg 27:1000–1004PubMedCrossRefGoogle Scholar
  141. 141.
    Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jr., Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114:e385–484PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff Verlag Darmstadt 2009

Authors and Affiliations

  1. 1.Department of MedicineLimmattal HospitalSchlierenSwitzerland
  2. 2.Cardiovascular CenterUniversity HospitalZurichSwitzerland

Personalised recommendations